WO2001073037A3 - R5 protein, a cell-surface protective antigen of group b streptococci - Google Patents

R5 protein, a cell-surface protective antigen of group b streptococci Download PDF

Info

Publication number
WO2001073037A3
WO2001073037A3 PCT/EP2001/003618 EP0103618W WO0173037A3 WO 2001073037 A3 WO2001073037 A3 WO 2001073037A3 EP 0103618 W EP0103618 W EP 0103618W WO 0173037 A3 WO0173037 A3 WO 0173037A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
streptococci
group
cell
surface protective
Prior art date
Application number
PCT/EP2001/003618
Other languages
French (fr)
Other versions
WO2001073037A2 (en
Inventor
Gursharan S Chhatwal
Sezgin Erdogan
Peter K Fagan
Carlos A Guzman
Susanne R Talay
Original Assignee
Biotechnolog Forschung Gmbh
Gursharan S Chhatwal
Sezgin Erdogan
Peter K Fagan
Carlos A Guzman
Susanne R Talay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnolog Forschung Gmbh, Gursharan S Chhatwal, Sezgin Erdogan, Peter K Fagan, Carlos A Guzman, Susanne R Talay filed Critical Biotechnolog Forschung Gmbh
Priority to AU48363/01A priority Critical patent/AU4836301A/en
Publication of WO2001073037A2 publication Critical patent/WO2001073037A2/en
Publication of WO2001073037A3 publication Critical patent/WO2001073037A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention relates to R5 protein, a cell-surface protective antigen of group B streptococci, a DNA-Sequence coding for R5 protein and compositions comprising R5 protein useful for vaccination against infection with group B streptococci.
PCT/EP2001/003618 2000-03-30 2001-03-29 R5 protein, a cell-surface protective antigen of group b streptococci WO2001073037A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48363/01A AU4836301A (en) 2000-03-30 2001-03-29 R5 protein, a new cell-surface protective antigen of group streptococci

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00106818.8 2000-03-30
EP00106818 2000-03-30
EP00122620.8 2000-10-17
EP00122620 2000-10-17

Publications (2)

Publication Number Publication Date
WO2001073037A2 WO2001073037A2 (en) 2001-10-04
WO2001073037A3 true WO2001073037A3 (en) 2002-04-18

Family

ID=26070758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003618 WO2001073037A2 (en) 2000-03-30 2001-03-29 R5 protein, a cell-surface protective antigen of group b streptococci

Country Status (2)

Country Link
AU (1) AU4836301A (en)
WO (1) WO2001073037A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 1 July 1999 (1999-07-01), TALAY S.R.: "Streptococcus agalactiae gene for R5 surface protein antigen", XP002177722 *

Also Published As

Publication number Publication date
WO2001073037A2 (en) 2001-10-04
AU4836301A (en) 2001-10-08

Similar Documents

Publication Publication Date Title
WO2005032582A3 (en) Immunogenic compositions for streptococcus pyogenes
WO2003054007A3 (en) Streptococcus antigens
WO2002022168A3 (en) Vaccine against streptococcus pneumoniae
MY125202A (en) Vaccine
HUP0302376A3 (en) Anti-tnf antibodies, compositions, methods and uses
WO2000076540A3 (en) Streptococcus pneumoniae proteins and vaccines
AU2002309706A1 (en) Novel meningitis conjugate vaccine
WO2002002606A3 (en) Immunisation against chlamydia pneumoniae
IL161968A0 (en) Anti-il-6 antibodies, compositions, methods and uses
WO2002013857A3 (en) A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
ZA200103580B (en) Aluminosilicate compositions, preparation and use.
WO2003051392A3 (en) Streptococcus pneumoniae vaccine
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2002024739A3 (en) Spas-1 cancer antigen
WO2002034773A3 (en) Streptococcal genes
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
EP1585477A4 (en) Anti-tnf antibodies, compositions, methods and uses
WO2003053338A3 (en) Novel chimeric rev, tat, and nef antigens
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2002028889A3 (en) Haemophilus influenzae antigens and corresponding dna fragments
WO2001073037A3 (en) R5 protein, a cell-surface protective antigen of group b streptococci
WO2002026785A3 (en) Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
AU2001254561A1 (en) Immunizing against hiv infection
AU2002342949A1 (en) Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other
EP1174469A3 (en) Linear polydialkylorganosiloxanes having polyoxyalkylene- and amino-functional groups, and also terminal alkoxy groups

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP